These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36708504)

  • 1. Comparison of the Recent Updates to the ACC/AHA and ESC Guidelines for the Management of Valvular Heart Disease: Similarities and Differences.
    Laskar N; Badiani S; Treibel T; Bhattacharyya S; Lloyd G
    Curr Cardiol Rep; 2023 Mar; 25(3):147-156. PubMed ID: 36708504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of American and European Guidelines for the Management of Patients With Valvular Heart Disease.
    Inanc IH; Cilingiroglu M; Iliescu C; NInios V; Matar F; Ates I; Toutouzas K; Hermiller J; Marmagkiolis K
    Cardiovasc Revasc Med; 2023 Feb; 47():76-85. PubMed ID: 36270966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients With Valvular Heart Disease.
    Alame AJ; Karatasakis A; Karacsonyi J; Danek BA; Sorajja P; Gössl M; Garcia S; Jneid H; Kakouros N; Martinez-Parachini JR; Resendes E; Kalsaria P; Roesle M; Rangan BV; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2017 Sep; 29(9):320-326. PubMed ID: 28420803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison.
    Coisne A; Lancellotti P; Habib G; Garbi M; Dahl JS; Barbanti M; Vannan MA; Vassiliou VS; Dudek D; Chioncel O; Waltenberger JL; Johnson VL; De Paulis R; Citro R; Pibarot P;
    J Am Coll Cardiol; 2023 Aug; 82(8):721-734. PubMed ID: 37587584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Fleisher LA; Jneid H; Mack MJ; McLeod CJ; O'Gara PT; Rigolin VH; Sundt TM; Thompson A
    J Am Coll Cardiol; 2017 Jul; 70(2):252-289. PubMed ID: 28315732
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy).
    Ezekowitz MD; Nagarakanti R; Noack H; Brueckmann M; Litherland C; Jacobs M; Clemens A; Reilly PA; Connolly SJ; Yusuf S; Wallentin L
    Circulation; 2016 Aug; 134(8):589-98. PubMed ID: 27496855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral anticoagulants and valvular atrial fibrillation: are they always contraindicated?
    Di Pasquale G; Zagnoni S; Riva L
    Intern Emerg Med; 2015 Feb; 10(1):21-4. PubMed ID: 25589164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative Management of Valvular Heart Disease in Patients Undergoing Non-Cardiac Surgery.
    Jalali Y; Jalali M; Števlík J
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Guyton RA; O'Gara PT; Ruiz CE; Skubas NJ; Sorajja P; Sundt TM; Thomas JD;
    J Am Coll Cardiol; 2014 Jun; 63(22):e57-185. PubMed ID: 24603191
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review.
    Owens RE; Kabra R; Oliphant CS
    Clin Cardiol; 2017 Jun; 40(6):407-412. PubMed ID: 28004413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Guyton RA; O'Gara PT; Ruiz CE; Skubas NJ; Sorajja P; Sundt TM; Thomas JD;
    J Am Coll Cardiol; 2014 Jun; 63(22):2438-88. PubMed ID: 24603192
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Nursing Management for Valvular Disease.
    Lee S
    Crit Care Nurs Clin North Am; 2019 Mar; 31(1):31-38. PubMed ID: 30736933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ESC/EACTS guidelines 2021 on the management of valvular heart diseases : What are the most important innovations?].
    Nettersheim FS; Baldus S
    Herz; 2022 Feb; 47(1):19-30. PubMed ID: 34609559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise Participation for Patients with Valvular Heart Disease: a Review of the Current Guidelines.
    Fernandez AB; Thompson PD
    Curr Cardiol Rep; 2021 Mar; 23(5):49. PubMed ID: 33740173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.
    Başaran Ö; Dogan V; Beton O; Tekinalp M; Aykan AÇ; Kalaycıoğlu E; Bolat I; Taşar O; Şafak Ö; Kalçık M; Yaman M; İnci S; Altıntaş B; Kalkan S; Kırma C; Biteker M;
    J Thromb Thrombolysis; 2017 Feb; 43(2):157-165. PubMed ID: 27848065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.